135 related articles for article (PubMed ID: 27275236)
21. CORRELATION OF C-REACTIVE PROTEIN AND COPD SEVERITY.
Milacić N; Milacić B; Milojković M; Ljubisavljevći S; Vodopić S; Hasanbegović M; Đurović M
Acta Clin Croat; 2016 Mar; 55(1):41-8. PubMed ID: 27333717
[TBL] [Abstract][Full Text] [Related]
22. Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification.
Lin YH; Wang WY; Hu SX; Shi YH
Pak J Med Sci; 2016; 32(6):1453-1458. PubMed ID: 28083044
[TBL] [Abstract][Full Text] [Related]
23. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.
Sin DD; Man SF
Circulation; 2003 Mar; 107(11):1514-9. PubMed ID: 12654609
[TBL] [Abstract][Full Text] [Related]
24. Relationship between Vitamin D Level and Serum TNF-α Concentration on the Severity of Chronic Obstructive Pulmonary Disease.
Ilyas M; Agussalim A; Megawati M; Massi N; Djaharuddin I; Bakri S; As'ad S; Arief M; Bahar B; Seweng A; Prihantono P
Open Access Maced J Med Sci; 2019 Jul; 7(14):2298-2304. PubMed ID: 31592277
[TBL] [Abstract][Full Text] [Related]
25. Proinflammatory cytokines in Egyptian elderly with chronic obstructive pulmonary disease.
Amer MS; Wahba HM; Ashmawi SS; Mabrouk RR; Sharaf Eldeen AA; Hamza SA
Lung India; 2010 Oct; 27(4):225-9. PubMed ID: 21139720
[TBL] [Abstract][Full Text] [Related]
26. CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions.
Prins HJ; Duijkers R; van der Valk P; Schoorl M; Daniels JMA; van der Werf TS; Boersma WG
Eur Respir J; 2019 May; 53(5):. PubMed ID: 30880285
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of therapy efficiency in patients with combined course of copd and osteoarthritis].
Хайменова ГС; Шилкина ЛН; Бабанина МЮ; Волченко ГВ; Ткаченко МВ; Ждан ВН
Wiad Lek; 2016; 69(2 Pt 2):214-8. PubMed ID: 27487536
[TBL] [Abstract][Full Text] [Related]
28. Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients.
Lazovic B
Med Arch; 2012; 66(3):159-60. PubMed ID: 22822613
[TBL] [Abstract][Full Text] [Related]
29. Proteoglycan 4 is a diagnostic biomarker for COPD.
Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC
Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097
[TBL] [Abstract][Full Text] [Related]
30. Association of High Sensitive CRP Level and COPD Assessment Test Scores with Clinically Important Predictive Outcomes in Stable COPD Patients.
Ghobadi H; Fouladi N; Beukaghazadeh K; Ansarin K
Tanaffos; 2015; 14(1):34-41. PubMed ID: 26221150
[TBL] [Abstract][Full Text] [Related]
31. Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters.
Patel N; Belcher J; Thorpe G; Forsyth NR; Spiteri MA
Respir Res; 2015 May; 16(1):62. PubMed ID: 26018813
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of C-reactive protein in chronic obstructive pulmonary disease.
Miniati M; Monti S; Bottai M; Cocci F; Fornai E; Lubrano V
Intern Emerg Med; 2011 Oct; 6(5):423-30. PubMed ID: 21249472
[TBL] [Abstract][Full Text] [Related]
33. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
[TBL] [Abstract][Full Text] [Related]
34. Factors affecting the length of stay and hospital readmission rates after an acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Wang Q; Pei G; Chen L; He Z
Ann Transl Med; 2022 Feb; 10(4):175. PubMed ID: 35280353
[TBL] [Abstract][Full Text] [Related]
35. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
[TBL] [Abstract][Full Text] [Related]
36. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
Barouchos N; Papazafiropoulou A; Iacovidou N; Vrachnis N; Barouchos N; Armeniakou E; Dionyssopoulou V; Mathioudakis AG; Christopoulou E; Koltsida S; Bassiakou E
Scand J Clin Lab Invest; 2015 Apr; 75(2):126-32. PubMed ID: 25598350
[TBL] [Abstract][Full Text] [Related]
37. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Wang RT; Li JY; Cao ZG; Li Y
Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
[TBL] [Abstract][Full Text] [Related]
38. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
39. Association of Plasma Heat Shock Protein 70 with Disease Severity, Smoking and Lung Function of Patients with Chronic Obstructive Pulmonary Disease.
Hlapčić I; Hulina-Tomašković A; Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rumora L
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32992869
[TBL] [Abstract][Full Text] [Related]
40. Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD.
Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3381-3387. PubMed ID: 30425468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
